{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T02:46:04Z","timestamp":1789785964292,"version":"4.0.1"},"reference-count":37,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2010,3,1]],"date-time":"2010-03-01T00:00:00Z","timestamp":1267401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Chinese National Basic Research and Development","award":["2006CB504100"],"award-info":[{"award-number":["2006CB504100"]}]},{"DOI":"10.13039\/501100001809","name":"Chinese National Natural Science Foundation","doi-asserted-by":"crossref","award":["30670885"],"award-info":[{"award-number":["30670885"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Mega-project of Science Research of China","award":["2009ZX09503-019"],"award-info":[{"award-number":["2009ZX09503-019"]}]},{"name":"National Mega-project of Science Research of China","award":["2009ZX09503-002"],"award-info":[{"award-number":["2009ZX09503-002"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2010,3]]},"DOI":"10.1016\/j.bbrc.2010.02.044","type":"journal-article","created":{"date-parts":[[2010,2,13]],"date-time":"2010-02-13T09:24:16Z","timestamp":1266053056000},"page":"637-642","source":"Crossref","is-referenced-by-count":13,"title":["Spred2 is involved in imatinib-induced cytotoxicity in chronic myeloid leukemia cells"],"prefix":"10.1016","volume":"393","author":[{"given":"Xiao-Yun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue-Feng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chu-Tse","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng-Jun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ni","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing-Fang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2010.02.044_bib1","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1126\/science.3460176","article-title":"The chronic myelogenous leukemia-specific P210 protein is the product of the bcr\/abl hybrid gene","volume":"233","author":"Ben-Neriah","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.bbrc.2010.02.044_bib2","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nm0596-561","article-title":"Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr\u2013Abl positive cells","volume":"2","author":"Druker","year":"1996","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2010.02.044_bib3","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1182\/blood.V83.5.1179.1179","article-title":"BCR\u2013ABL maintains resistance of chronic myelogenous leukemia cells to apoptotic cell death","volume":"83","author":"McGahon","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2010.02.044_bib4","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1038\/nrc1567","article-title":"Mechanisms of BCR\u2013ABL in the pathogenesis of chronic myelogenous leukaemia","volume":"5","author":"Ren","year":"2005","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2010.02.044_bib5","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1002\/j.1460-2075.1994.tb06319.x","article-title":"Bcr\u2013Abl oncoproteins bind directly to activators of the Ras signalling pathway","volume":"13","author":"Puil","year":"1994","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2010.02.044_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/0092-8674(95)90277-5","article-title":"Alternative signals to Ras for hematopoietic transformation by the BCR\u2013ABL oncogene","volume":"82","author":"Goga","year":"1995","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2010.02.044_bib7","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1084\/jem.181.1.307","article-title":"Genetic requirement for Ras in the transformation of fibroblasts and hematopoietic cells by the Bcr\u2013Abl oncogene","volume":"181","author":"Sawyers","year":"1995","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2010.02.044_bib8","first-page":"2589","article-title":"The BCR\u2013ABL tyrosine kinase inhibits apoptosis by activating a Ras-dependent signaling pathway","volume":"12","author":"Cortez","year":"1996","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.02.044_bib9","doi-asserted-by":"crossref","first-page":"5491","DOI":"10.1093\/emboj\/cdg540","article-title":"Activation of sphingosine kinase 1 by ERK","volume":"22","author":"Pitson","year":"2003","journal-title":"EMBO J."},{"key":"10.1016\/j.bbrc.2010.02.044_bib10","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1182\/blood-2004-02-0749","article-title":"Identification of mcl-1 as a BCR\/ABL-dependent target in chronic myeloid leukemia (CML): evidence for cooperative antileukemic effects of imatinib and mcl-1 antisense oligonucleotides","volume":"105","author":"Aichberger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2010.02.044_bib11","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1056\/NEJM200104053441401","article-title":"Efficacy and safety of a specific inhibitor of the BCR\u2013ABL tyrosine kinase in chronic myeloid leukemia","volume":"344","author":"Druker","year":"2001","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2010.02.044_bib12","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nrc2126","article-title":"Second generation inhibitors of BCR\u2013ABL for the treatment of imatinib-resistant chronic myeloid leukaemia","volume":"7","author":"Weisberg","year":"2007","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2010.02.044_bib13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/35088082","article-title":"Spred is a Sprouty-related suppressor of Ras signalling","volume":"412","author":"Wakioka","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2010.02.044_bib14","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1016\/S0006-291X(03)00259-6","article-title":"Molecular cloning of mammalian Spred-3 which suppresses tyrosine kinase-mediated Erk activation","volume":"302","author":"Kato","year":"2003","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbrc.2010.02.044_bib15","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/bies.20632","article-title":"Getting a first clue about SPRED functions","volume":"29","author":"Bundschu","year":"2007","journal-title":"BioEssays"},{"key":"10.1016\/j.bbrc.2010.02.044_bib16","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1038\/sj.onc.1207759","article-title":"The Sprouty-related protein, Spred, inhibits cell motility, metastasis, and Rho-mediated actin reorganization","volume":"23","author":"Miyoshi","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.02.044_bib17","doi-asserted-by":"crossref","first-page":"52543","DOI":"10.1074\/jbc.M405189200","article-title":"Spred-1 negatively regulates interleukin-3-mediated ERK\/Mitogen-activated Protein (MAP) Kinase activation in hematopoietic cells","volume":"279","author":"Nonami","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.02.044_bib18","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1042\/BJ20041284","article-title":"Distinct requirements for the Sprouty domain for functional activity of Spred proteins","volume":"388","author":"King","year":"2005","journal-title":"Biochem. J."},{"key":"10.1016\/j.bbrc.2010.02.044_bib19","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1084\/jem.20040616","article-title":"Spred-1 negatively regulates allergen-induced airway eosinophilia and hyperresponsiveness","volume":"201","author":"Inoue","year":"2005","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2010.02.044_bib20","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1209635","article-title":"Spreds, inhibitors of the Ras\/ERK signal transduction, are dysregulated in human hepatocellular carcinoma and linked to the malignant phenotype of tumors","volume":"25","author":"Yoshida","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.02.044_bib21","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1084\/jem.20030830","article-title":"Spred-2 suppresses aorta-gonad-mesonephros hematopoiesis by inhibiting MAP Kinase activation","volume":"199","author":"Nobuhisa","year":"2004","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.bbrc.2010.02.044_bib22","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2008.06.011","article-title":"Effects of silibinin on cell growth and invasive properties of a human hepatocellular carcinoma cell line, HepG-2, through inhibition of extracellular signal-regulated kinase","volume":"591","author":"Momeny","year":"2008","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbrc.2010.02.044_bib23","doi-asserted-by":"crossref","first-page":"17515","DOI":"10.1074\/jbc.M313816200","article-title":"RKIP sensitizes prostate and breast cancer cells to drug-induced apoptosis","volume":"279","author":"Chatterjee","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbrc.2010.02.044_bib24","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.4049\/jimmunol.179.8.5441","article-title":"Regulation of tumor cell sensitivity to TRAIL-induced apoptosis by the metastatic suppressor Raf kinase inhibitor protein via Yin Yang 1 inhibition and death receptor 5 up-regulation","volume":"179","author":"Baritaki","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.bbrc.2010.02.044_bib25","doi-asserted-by":"crossref","first-page":"7904","DOI":"10.1038\/sj.onc.1210587","article-title":"Sphingosine kinase-1 mediates BCR\/ABL-induced upregulation of Mcl-1 in chronic myeloid leukemia cells","volume":"26","author":"Li","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.02.044_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1038\/leu.2008.95","article-title":"Sphingosine kinase-1 is a downstream regulator of imatinib-induced apoptosis in chronic myeloid leukemia cells","volume":"22","author":"Bonhoure","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2010.02.044_bib27","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1016\/j.exphem.2006.05.005","article-title":"Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p","volume":"34","author":"Lu","year":"2006","journal-title":"Exp. Hematol."},{"key":"10.1016\/j.bbrc.2010.02.044_bib28","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1365-2141.2007.06711.x","article-title":"Activation of sphingosine kinase mediates suppressive effect of interleukin-6 on human multiple myeloma cell apoptosis","volume":"138","author":"Li","year":"2007","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.bbrc.2010.02.044_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrc969","article-title":"Targeting RAS signalling pathways in cancer therapy","volume":"3","author":"Downward","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2010.02.044_bib30","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1158\/1535-7163.MCT-04-0297","article-title":"Raf kinase as a target for anticancer therapeutics","volume":"4","author":"Sridhar","year":"2005","journal-title":"Mol. Cancer Ther."},{"key":"10.1016\/j.bbrc.2010.02.044_bib31","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1038\/sj.onc.1210422","article-title":"Targeting the Raf\u2013MEK\u2013ERK mitogen-activated protein kinase cascade for the treatment of cancer","volume":"26","author":"Roberts","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.bbrc.2010.02.044_bib32","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1158\/1078-0432.CCR-07-4790","article-title":"Advances in targeting the Ras\/Raf\/MEK\/Erk mitogen-activated protein kinase cascade with MEK inhibitors for cancer therapy","volume":"14","author":"Friday","year":"2008","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.bbrc.2010.02.044_bib33","doi-asserted-by":"crossref","first-page":"14398","DOI":"10.1073\/pnas.222222699","article-title":"Inhibitors of Ras\u2013Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells","volume":"99","author":"Kato-Stankiewicz","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1016\/j.bbrc.2010.02.044_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/sj.leu.2403241","article-title":"JAK\/STAT, Raf\/MEK\/ERK, PI3K\/Akt and BCR\u2013ABL in cell cycle progression and leukemogenesis","volume":"18","author":"Steelman","year":"2004","journal-title":"Leukemia"},{"key":"10.1016\/j.bbrc.2010.02.044_bib35","first-page":"188","article-title":"Pharmacologic mitogen-activated protein\/extracellular signal-regulated kinase kinase\/mitogen-activated protein kinase inhibitors interact synergistically with STI571 to induce apoptosis in Bcr\/Abl-expressing human leukemia cells","volume":"62","author":"Yu","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbrc.2010.02.044_bib36","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2006-09-045039","article-title":"MEK12 inhibitors sensitize Bcr\/Abl+ human leukemia cells to the dual Abl\/Src inhibitor BMS-354\/825","volume":"109","author":"Nguyen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bbrc.2010.02.044_bib37","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1182\/blood-2007-09-112573","article-title":"BMS-214662 potently induces apoptosis of chronic myeloid leukemia stem and progenitor cells and synergizes with tyrosine kinase inhibitors","volume":"111","author":"Copland","year":"2008","journal-title":"Blood"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1000255X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X1000255X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,27]],"date-time":"2020-05-27T23:13:17Z","timestamp":1590621197000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X1000255X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3]]},"references-count":37,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010,3]]}},"alternative-id":["S0006291X1000255X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2010.02.044","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2010,3]]}}}